MDxHealth Q4 2023 GAAP EPS $(0.390) Misses $(0.150) Estimate, Sales $19.398M Beat $18.136M Estimate
MDxHealth Q4 2023 GAAP EPS $(0.390) Misses $(0.150) Estimate, Sales $19.398M Beat $18.136M Estimate
MDxHealth 2023年第四季度GAAP每股收益美元（0.390）未达到预期（0.150），销售额为1,9398万美元，超过预期的1,813.6亿美元
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.390) per share which missed the analyst consensus estimate of $(0.150) by 160 percent. The company reported quarterly sales of $19.398 million which beat the analyst consensus estimate of $18.136 million by 6.96 percent. This is a 50.48 percent increase over sales of $12.891 million the same period last year.
MDxHealth（纳斯达克股票代码：MDXH）公布的季度亏损为每股0.390美元，比分析师普遍预期的0.150美元（0.150美元）低160％。该公司公布的季度销售额为1939.8万美元，比分析师共识估计的1813.6万美元高出6.96％。这比去年同期的1289.1万美元的销售额增长了50.48％。